Liminatus Pharma Inc. has entered into a settlement and release agreement with Alta Partners, LLC, resulting in the issuance of 350,000 shares of its common stock to Alta Partners in exchange for the cancellation of 1,000,000 warrants to purchase shares of common stock. The shares have a par value of $0.0001 each. No commission or remuneration was involved in this transaction.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.